不同亞型間質性肺異常特征及預后研究進展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

馬麗 ,  陳亞娟

重慶醫科大學附屬第一醫院吸與危重癥醫學科（重慶 400016）;

Corresponding?author：

陳亞娟, Email: yajuanchencqmu@sina.com

Keywords：

DOI：

10.7507/1671-6205.202503001

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 馬麗, 陳亞娟. 不同亞型間質性肺異常特征及預后研究進展. Chinese Journal of Respiratory and Critical Care Medicine, 2025, 24(12): 887-891. doi: 10.7507/1671-6205.202503001 Copy

1.	Wijsenbeek M, Suzuki A, Maher TM. Interstitial lung diseases. Lancet, 2022, 400(10354): 769-786.
2.	Putman R K, Hatabu H, Araki T, et al. Association Between Interstitial Lung Abnormalities and All-Cause Mortality. Jama, 2016, 315(7): 672-681.
3.	Araki T, Putman RK, Hatabu H, et al. Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study. Am J Respir Crit Care Med, 2016, 194(12): 1514-1522.
4.	Hatabu H, Hunninghake G M, Richeldi L, et al. Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society. Lancet Resp Med, 2020, 8(7): 726-737.
5.	Menon A A, Putman R K, Sanders J L, et al. Interstitial Lung Abnormalities, Emphysema, and Spirometry in Smokers. Chest, 2022, 161(4): 999-1010.
6.	Ash SY, Harmouche R, Ross JC, et al. Interstitial Features at Chest CT Enhance the Deleterious Effects of Emphysema in the COPDGene Cohort. Radiology, 2018, 288(2): 600-609.
7.	Kim MS, Choe J, Hwang HJ, et al. Interstitial lung abnormalities (ILA) on routine chest CT: Comparison of radiologists’ visual evaluation and automated quantification. Eur J Radiol, 2022, 157: 10564.
8.	Escalon JG, Podolanczuk AJ, Aronson KI, et al. Practice patterns in reporting interstitial lung abnormality at a tertiary academic medical center. Clin. Imaging, 2023, 104.109996.
9.	Zhang Y, Wan H, Richeldi L, et al. Reticulation Is a Risk Factor of Progressive Subpleural Nonfibrotic Interstitial Lung Abnormalities. Am J Respir Crit Care Med, 2022, 206(2): 178-85.
10.	Buendía-Roldán I, Fernandez R, Mejía M, et al. Risk factors associated with the development of interstitial lung abnormalities. Eur Resp J 2021, 58(2). 2003005.
11.	Balata H, Punjabi A, Chaudhuri N, et al. The detection, assessment and clinical evolution of interstitial lung abnormalities identified through lung cancer screening. ERJ Open Res, 2023, 9(3): .00632-2022.
12.	Lee JE, Chae KJ, Suh YJ, et al. Prevalence and Long-term Outcomes of CT Interstitial Lung Abnormalities in a Health Screening Cohort. Radiology, 2023, 306(2): .e221172.
13.	Putman RK, Gudmundsson G, Axelsson GT, et al. Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality. Am J Respir Crit Care Med, 2019, 200(2): 175-183.
14.	Doyle T J, Washko G R, Fernandez I E, et al. Interstitial Lung Abnormalities and Reduced Exercise Capacity. Am J Respir Crit Care Med, 2012, 185(7): 756-762.
15.	Hata A, Yanagawa M, Miyata T, et al. Association between interstitial lung abnormality and mortality in patients with esophageal cancer. Jpn J Radiol, 2024, 42(8): 841-851.
16.	Chae KJ, Lim S, Seo JB, et al. Interstitial Lung Abnormalities at CT in the Korean National Lung Cancer Screening Program: Prevalence and Deep Learning–based Texture Analysis. Radiology, 2023, 307(4): .e222828.
17.	Jin G Y, Lynch D, Chawla A, et al. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology, 2013, 268(2): 563-571.
18.	Ito M, Katano T, Okada H, et al. Subpleural fibrotic interstitial lung abnormalities are implicated in non-small cell lung cancer radiotherapy outcomes. Radiol Oncol, 2023, 57(2): 229-238.
19.	Kikuchi R, Watanabe Y, Okuma T, et al. Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities. Cancer Immunol. Immunother, 2024, 73(11): 211.
20.	Hida T, Nishino M, Hino T, et al. Traction Bronchiectasis/Bronchiolectasis is Associated with Interstitial Lung Abnormality Mortality. Eur J Radiol, 2020, 129: 109073.
21.	Hata A, Hino T, Putman R K, et al. Traction Bronchiectasis/Bronchiolectasis on CT Scans in Relationship to Clinical Outcomes and Mortality: The COPDGene Study. Radiology, 2022, 304(3): 694-701.
22.	Liu Y, Jiang Y, Sun Y. Interstitial lung abnormality in COPD is associated with higher prevalence of antinuclear antibody. Expert Rev Respir Med, 2023, 17(8): 735-742.

1. Wijsenbeek M, Suzuki A, Maher TM. Interstitial lung diseases. Lancet, 2022, 400(10354): 769-786.
2. Putman R K, Hatabu H, Araki T, et al. Association Between Interstitial Lung Abnormalities and All-Cause Mortality. Jama, 2016, 315(7): 672-681.
3. Araki T, Putman RK, Hatabu H, et al. Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study. Am J Respir Crit Care Med, 2016, 194(12): 1514-1522.
4. Hatabu H, Hunninghake G M, Richeldi L, et al. Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society. Lancet Resp Med, 2020, 8(7): 726-737.
5. Menon A A, Putman R K, Sanders J L, et al. Interstitial Lung Abnormalities, Emphysema, and Spirometry in Smokers. Chest, 2022, 161(4): 999-1010.
6. Ash SY, Harmouche R, Ross JC, et al. Interstitial Features at Chest CT Enhance the Deleterious Effects of Emphysema in the COPDGene Cohort. Radiology, 2018, 288(2): 600-609.
7. Kim MS, Choe J, Hwang HJ, et al. Interstitial lung abnormalities (ILA) on routine chest CT: Comparison of radiologists’ visual evaluation and automated quantification. Eur J Radiol, 2022, 157: 10564.
8. Escalon JG, Podolanczuk AJ, Aronson KI, et al. Practice patterns in reporting interstitial lung abnormality at a tertiary academic medical center. Clin. Imaging, 2023, 104.109996.
9. Zhang Y, Wan H, Richeldi L, et al. Reticulation Is a Risk Factor of Progressive Subpleural Nonfibrotic Interstitial Lung Abnormalities. Am J Respir Crit Care Med, 2022, 206(2): 178-85.
10. Buendía-Roldán I, Fernandez R, Mejía M, et al. Risk factors associated with the development of interstitial lung abnormalities. Eur Resp J 2021, 58(2). 2003005.
11. Balata H, Punjabi A, Chaudhuri N, et al. The detection, assessment and clinical evolution of interstitial lung abnormalities identified through lung cancer screening. ERJ Open Res, 2023, 9(3): .00632-2022.
12. Lee JE, Chae KJ, Suh YJ, et al. Prevalence and Long-term Outcomes of CT Interstitial Lung Abnormalities in a Health Screening Cohort. Radiology, 2023, 306(2): .e221172.
13. Putman RK, Gudmundsson G, Axelsson GT, et al. Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality. Am J Respir Crit Care Med, 2019, 200(2): 175-183.
14. Doyle T J, Washko G R, Fernandez I E, et al. Interstitial Lung Abnormalities and Reduced Exercise Capacity. Am J Respir Crit Care Med, 2012, 185(7): 756-762.
15. Hata A, Yanagawa M, Miyata T, et al. Association between interstitial lung abnormality and mortality in patients with esophageal cancer. Jpn J Radiol, 2024, 42(8): 841-851.
16. Chae KJ, Lim S, Seo JB, et al. Interstitial Lung Abnormalities at CT in the Korean National Lung Cancer Screening Program: Prevalence and Deep Learning–based Texture Analysis. Radiology, 2023, 307(4): .e222828.
17. Jin G Y, Lynch D, Chawla A, et al. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology, 2013, 268(2): 563-571.
18. Ito M, Katano T, Okada H, et al. Subpleural fibrotic interstitial lung abnormalities are implicated in non-small cell lung cancer radiotherapy outcomes. Radiol Oncol, 2023, 57(2): 229-238.
19. Kikuchi R, Watanabe Y, Okuma T, et al. Outcome of immune checkpoint inhibitor treatment in non-small cell lung cancer patients with interstitial lung abnormalities: clinical utility of subcategorizing interstitial lung abnormalities. Cancer Immunol. Immunother, 2024, 73(11): 211.
20. Hida T, Nishino M, Hino T, et al. Traction Bronchiectasis/Bronchiolectasis is Associated with Interstitial Lung Abnormality Mortality. Eur J Radiol, 2020, 129: 109073.
21. Hata A, Hino T, Putman R K, et al. Traction Bronchiectasis/Bronchiolectasis on CT Scans in Relationship to Clinical Outcomes and Mortality: The COPDGene Study. Radiology, 2022, 304(3): 694-701.
22. Liu Y, Jiang Y, Sun Y. Interstitial lung abnormality in COPD is associated with higher prevalence of antinuclear antibody. Expert Rev Respir Med, 2023, 17(8): 735-742.

Previous Article
氣道壓力釋放通氣聯合俯臥位通氣救治社區獲得性皮特不動桿菌肺炎致重度急性呼吸窘迫綜合征一例
Next Article
妊娠期肺栓塞

Chinese Journal of Respiratory and Critical Care Medicine

不同亞型間質性肺異常特征及預后研究進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content